Skip to main content
. 2018 May 28;9:1170. doi: 10.3389/fimmu.2018.01170

Table 1.

Tumor development promoted by TNFR2-mediated signaling in tumor or tumor-associated cells.

Cancer type Impacts of TNF receptor 2 (TNFR2) expression on various cells
Breast cancer Promoting tumor cell growth (49); inhibiting programmed death of tumor cells (48); stabilizing myeloid-derived suppressor cells (MDSC) (91); and relating to suppressive function of regulatory T (Treg) cells (82)
Colon cancer Advancing carcinogenesis of epithelia cells (5961); promoting tumor cell proliferation (55, 56); enhancing angiogenesis by upregulating VEGF-A in tumor cells (56); inducing cancer-associated fibroblasts (100); activating Treg cells (78, 105); and supporting metastasis (92)
Cervical cancer Facilitating tumorigenesis (58)
Fibrosarcoma Promoting MDSC accumulation (85)
Liver cancer Expanding Treg cells (78) and promoting tumoral accumulation of MDSC by inducing specific chemokine receptor (87)
Lung cancer Helping to form metastasis niche by stabilizing MDSC (92); promoting VEGF release and anti-apoptotic ability of tumor cells (50, 51); and associating with inhibitory effects of Treg cells (67, 82)
Melanoma Maintaining Treg cells (71); contributing to T cell exhaustion (80)
Ovarian cancer Acting as oncogene in tumor cells (104); expanding Treg cells (104); and promoting Treg cells to impair T-helper 1 immunity (77)
Renal cancer Driving proliferation of tumor stem cells (54) and accelerating tumor cell division (53, 79)
Skin cancer Advancing malignant transformation of epidermal cells (40)
Plasmacytoma Driving MDSC expansion (85)
Lymphoma Enhancing angiogenesis by inducing interleukin-6 secretion from malignant cells (52) and augmenting activation-induced death of cytotoxic T cells (79)
Leukemia Relating to Treg cell expansion (102, 103)

References exploring biological functions of TNFR2 in tumorigenesis, tumor progression, anti-apoptosis, or non-specified other processes in human cancer and murine tumor models within the last 10 years.